• Explore /
  • Poster
  • / The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment.

The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment.

Abstract Poster

Authors

Peter Albers

Peter Albers

Department of Urology, Heinrich-Heine-University, Duesseldorf, Germany

Peter Albers , Andreas Hiester , Robert Grosse Siemer , Achim Lusch

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Testicular Cancer

Clinical Trial Registration Number

NCT 2015053664

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 507)

DOI

10.1200/JCO.2019.37.7_suppl.507

Abstract #

507

Poster Bd #

B7

Abstract Disclosures

Similar Posters

First Author: Peter Albers

First Author: Armelle Vinceneux

First Author: Tian Zhang

Poster

2024 ASCO Genitourinary Cancers Symposium

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

First Author: Antoine Morin Coulombe